Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Interest Expense : $-0.05 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Biodexa Pharmaceuticals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Biodexa Pharmaceuticals's interest expense for the six months ended in Dec. 2023 was $ -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.05 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Biodexa Pharmaceuticals's Operating Income for the six months ended in Dec. 2023 was $ -4.77 Mil. Biodexa Pharmaceuticals's Interest Expense for the six months ended in Dec. 2023 was $ -0.02 Mil. Biodexa Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biodexa Pharmaceuticals Interest Expense Historical Data

The historical data trend for Biodexa Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biodexa Pharmaceuticals Interest Expense Chart

Biodexa Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.13

-0.05

-0.06

-0.07

-0.05

Biodexa Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.03	-0.03	-0.04	-0.03	-0.02

Biodexa Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.05 Mil.

Biodexa Pharmaceuticals (NAS:BDRX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biodexa Pharmaceuticals's Interest Expense for the six months ended in Dec. 2023 was $-0.02 Mil. Its Operating Income for the six months ended in Dec. 2023 was $-4.77 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was $0.37 Mil.

Biodexa Pharmaceuticals's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Biodexa Pharmaceuticals did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biodexa Pharmaceuticals Plc (NAS:BDRX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

5MP:Germany

Address

1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ

Website

https://www.biodexapharma.com

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.